Women in low-income populations may be at a higher risk of breast cancer mortality due to access barriers. How has COVID-19 affected their ability to get breast cancer screenings?
A meta-analysis suggests that patients with cancer may be twice as likely as non-cancer patients to have a breakthrough infection after being fully vaccinated.
Registry data show significant decreases in 14-day and 3-month case-fatality rates.
During the peak of the pandemic, CT for cancer screening decreased 82%.
The risk of any cancer increased in association with first-trimester exposure.
Between 2015 and 2019, Black and Hispanic patients were underrepresented in trials of colorectal, lung, and prostate cancer.
Patients experienced clinically meaningful benefits at various time points.
Recent studies showed associations between quality of life scores and survival in lung and prostate cancer as well as renal cell carcinoma.
Fasting-mimicking diets induce metabolic and immunologic changes that might enhance the effects of standard antineoplastic therapy.
The incidence of grade 3-5 toxic effects was lower in the intervention group.
